![]() |
|
|||
|
THURSDAY, Jan. 26 (HealthDay News) -- A new industry-funded study suggests that a molecular test can provide insight into whether patients are at high risk of a relapse after surgical treatment for a form of lung cancer.
|
| Thread Tools | |
| Display Modes | |
|
|